(Q28478561)
Statements
The cytokine release inhibitory drug CRID3 targets ASC oligomerisation in the NLRP3 and AIM2 inflammasomes (English)
0 references
2011
0 references
6
0 references
12
0 references
e29539
0 references
22 December 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference